Why listening to your heart is good for your health.




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Why listening to your heart is good for your health.
Released on: May 22, 2015. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Coronary Artery Disease (CAD) is the most common heart disease affecting up to 50% of the westernised population during their lifetime.
  • Summary
  • Transcript
  • Participants
Coronary Artery Disease (CAD) is the most common heart disease affecting up to 50% of the westernised population during their lifetime. By combining early diagnosis and intervention it is possible to reduce the progression of CAD and thereby reduce the disease burden. Acarix CEO, Stig Visti Andersen explains to PharmaVentures' Fintan Walton how the Acarix CADScorĀ® System has been designed to be an all-in-one equipment in the sense that the heart signal will be recorded, processed and displayed as a patient specific score, the CAD-score, on the device screen.
Coronary Artery Disease (CAD) is the most common heart disease affecting up to 50% of the westernised population during their lifetime. By combining early diagnosis and intervention it is possible to reduce the progression of CAD and thereby reduce the disease burden. Acarix CEO Stig Visti Andersen, explains to PharmaVentures' Fintan Walton how the Acarix CADScorĀ® System has been designed to be an all-in-one equipment in the sense that the heart signal will be recorded, processed and displayed as a patient specific score, the CAD-score, on the device screen.
Coronary Artery Disease (CAD) is the most common heart disease affecting up to 50% of the westernised population during their lifetime. By combining early diagnosis and intervention it is possible to reduce the progression of CAD and thereby reduce the disease burden. Acarix CEO Stig Visti Andersen explains to PharmaVentures' Fintan Walton how the Acarix CADScorĀ® System has been designed to be an all-in-one equipment in the sense that the heart signal will be recorded, processed and displayed as a patient specific score, the CAD-score, on the device screen.